SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-059174
Filing Date
2022-12-01
Accepted
2022-12-01 16:02:39
Documents
1
Period of Report
2022-11-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3165
  Complete submission text file 0001209191-22-059174.txt   4883
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACER THERAPEUTICS INC. 222 THIRD STREET CAMBRIDGE MA 02142
Business Address
Schelling Chris (Reporting) CIK: 0001717241 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33004 | Film No.: 221438828